Log In
BCIQ
Print this Print this
 

EB-101

  Manage Alerts
Collapse Summary General Information
Company Abeona Therapeutics Inc.
DescriptionCollagen type VII (COL7A1) gene-corrected graft
Molecular Target Collagen type VII (COL7A1)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationBlistering disorder
Indication DetailsTreat recessive dystrophic epidermolysis bullosa
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/09/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today